Company:Bioserenity

From HandWiki
BioSerenity
TypePrivately held company
FoundedJanuary 29, 2014 (2014-01-29)
FounderPierre-Yves Frouin
Headquarters
Paris
,
France
Area served
US, France, China
ProductsNeuronaute, Cardionaute, Cardioskin[1]
ServicesNeurophy, Cardiophy, Somnophy[2]
Number of employees
400 (2019)
Websitewww.bioserenity.com

BioSerenity is a medtech company created in 2014 that develops ambulatory medical devices to help diagnose and monitor patients with chronic diseases[3] such as epilepsy.[4] The medical devices are composed of medical sensors, smart clothing or consumables,[5] a smartphone app for Patient Reported Outcome, and a web platform to perform data analysis through Medical Artificial Intelligence[6][7] for detection of digital biomarkers.[8] The company initially focused on Neurology,[9] a domain in which it reported contributing to the diagnosis of 30 000 patients per year.[10] It now also operates in Sleep Disorders and Cardiology.[11] BioSerenity reported it provides pharmaceutical companies with solutions for companion diagnostics.[12]

Company history

BioSerenity was founded in 2014, by Pierre-Yves Frouin. The company was initially hosted at the ICM Institute (Institute du Cerveau et de la Moëlle épinière),[13][14] in Paris, France.

Fund Raising

  • June 8, 2015 : The company raised a $4 million seed round with Kurma Partners and IdInvest Partners[15]
  • September 20, 2017 : The company raised a $17 million series A round with LBO France, IdInvest Partners and BPI France[16]
  • June 18, 2019 : The company raised a $70 million series B round with Dassault Systèmes, IdInvest Partners, LBO France and BPI France[17]
  • November 13, 2023 : The company raised a 24M€ series C round with Jolt Capital[18]

Acquisitions

In 2019, BioSerenity announced the acquisition of the American Company SleepMed[19] and Novasom[20]

Development

In 2019, was working with over 200 Hospitals.

In 2020, BioSerenity was one of the five French manufacturers (Savoy, BB Distrib, Celluloses de Brocéliande, Chargeurs) working on the production of sanitary equipment including FFP2 masks at request of the French government.[21]

In 2021, the Neuronaute was used by approximately 30,000 patients per year.[22]

In 2023, the company launched the Icecap, a single use EEG solution[23][24] and its A.I. model for Sleep Disorders with teams from Stanford University.[25][26][27]

In 2025, the company was performing more than 45,000 EEGs (electroencephalograms), 8,000 PSGs (polysomnographies), and 5,000 ECGs (electrocardiograms) each year.[28] The company launched a new EEG A.I. model[29] and signed an agreement to distribute its solutions in the USA through Stratus.[30]

In November 2025, Emmanuel Mougeotte, former CEO of CompuGroup Medical France, became CEO of the company [31] and in January 2026, Pierre-Yves Frouin, founder of BioSerenity concluded his tenure and exited the company.[32]

Awards

  • BioSerenity is one of the Disrupt 100[33]
  • BioSerenity joined the Next40[34]
  • BioSerenity was selected by Microsoft and AstraZeneca in their initiative AI Factory for Health[35]
  • BioSerenity accelerated at Stanford's University StartX program[36]

References

  1. Fouassier, David (2020). "Assessment of signal quality measured with a smart 12-lead ECG acquisition T-shirt". Annals of Noninvasive Electrocardiology (Wiley) 25 (1). doi:10.1111/anec.12682. PMID 31339208. (citing PMID 31339208)
  2. Cairns, Alyssa (February 2019). "Comparison of the macro and microstructure of sleep in a sample of sleep clinic hypersomnia cases.". Neurobiology of Sleep and Circadian Rhythms (Elsevier) 6: 62–69. doi:10.1016/j.nbscr.2019.02.001. PMID 31236521. (citing PMID 31236521)
  3. "La HealthTech, la mine d'or méconnue de la French Tech" (in fr). February 12, 2020. https://www.latribune.fr/technos-medias/innovation-et-start-up/la-healthtech-la-mine-d-or-meconnue-de-la-french-tech-839460.html. 
  4. "NHS could soon use smart outfit to diagnose epilepsy" (in English). June 1, 2016. https://www.newscientist.com/article/2091426-nhs-could-soon-use-smart-outfit-to-diagnose-epilepsy/. 
  5. "Textiles connectés, où quand les vêtements scrutent les mouvements" (in fr). Le Temps. January 29, 2016. https://www.letemps.ch/sciences/textiles-connectes-vetements-scrutent-mouvements. 
  6. Le Van Quyen, Michel (2018). "An Ensemble Learning Approach to Detect Epileptic Seizures from Long Intracranial EEG Recordings". 2018 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP). Calgary: IEEE. pp. 856–860. doi:10.1109/ICASSP.2018.8461489. ISBN 978-1-5386-4658-8. https://ieeexplore.ieee.org/document/8461489/authors#authors. 
  7. "Intelligence artificielle : la course aux bases de données". Le Monde.fr. May 8, 2017. https://www.lemonde.fr/sciences/article/2017/05/08/intelligence-artificielle-la-course-aux-bases-de-donnees_5124406_1650684.html. 
  8. "BioSerenity : l'intelligence artificielle et la data au service du patient" (in fr). September 20, 2019. https://www.lesechos.fr/partenaires/bpifrance/bioserenity-lintelligence-artificielle-et-la-data-au-service-du-patient-1133273. 
  9. "Wearable technology: Clothing designed to save your life" (in en). BBC News. August 25, 2014. https://www.bbc.com/news/business-28844162. 
  10. "These Sensor-Studded Smart Clothes Just Might Save Your Life" (in English). September 7, 2021. https://www.wsj.com/articles/these-sensor-studded-smart-clothes-just-might-save-your-life-11631030505. 
  11. "'Cardioskin' T-shirt tracks heart rhythm around the clock" (in en). September 13, 2018. https://www.cardiovascularbusiness.com/topics/electrophysiology-arrhythmia/cardioskin-t-shirt-tracks-heart-rhythm-24-hours. 
  12. "Dassault Systèmes Continues to Demonstrate Its Commitment to Life Sciences for Patient Experience by Investing in BioSerenity" (in en). June 19, 2019. https://markets.businessinsider.com/news/stocks/dassault-syst-mes-continues-to-demonstrate-its-commitment-to-life-sciences-for-patient-experience-by-investing-in-bioserenity-1028285932. 
  13. "BioSerenity". https://ipeps.icm-institute.org/startups/bioserenity.html. 
  14. "Un tee-shirt qui diagnostique l'épilepsie". Le Monde.fr. September 30, 2014. https://www.lemonde.fr/sciences/article/2014/09/30/un-tee-shirt-qui-diagnostique-l-epilepsie_4497111_1650684.html. 
  15. "KURMA ANNOUNCES THE FIRST INVESTMENT OF THEIR NEWLY LAUNCHED DIAGNOSTICS FUNDS IN THE START UP COMPANY BIOSERENITY". June 8, 2015. http://kurma-partners-website-backend.cdn.prismic.io/kurma-partners-website-backend%2F283e2b75-0733-4ea1-8fd2-5a7bc264a21c_pr_kdx_bioserenity_8__june_2015.pdf. 
  16. "BioSerenity, champion français de la e-santé, lève 15 millions d'Euros" (in fr). September 20, 2017. https://lyonbiopole.com/wp/wp-content/uploads/2017/10/FR_CP_BioSerenity_leve_15MEUR-20092017.pdf. 
  17. "BioSerenity, champion MedTech spécialisé dans les solutions de diagnostic et de télé-expertise, lève 65 millions d'euros pour étendre son activité aux Etats-Unis et approfondir ses solutions IoT et d'Intelligence Artificielle" (in fr). June 18, 2019. https://www.lbofrance.com/var/fichiers/cp-serie-b-18062019-frana-ais.pdf. 
  18. "Jolt Capital Fuels BioSerenity's MedTech Revolution with €24M Investment" (in en-US). 2023-11-14. https://technews180.com/jolt-capital-fuels-bioserenitys-medtech-revolution-with-e24m-investment/. 
  19. Loye, Deborah (September 23, 2019). "BioSerenity rachète l'américain SleepMed" (in fr). https://business.lesechos.fr/entrepreneurs/financer-sa-creation/0601908938738-bioserenity-rachete-l-americain-sleepmed-331844.php#Xtor=AD-6000. 
  20. Christie, Jim (September 24, 2019). "IN BRIEF: BioSerenity to buy NovaSom out of bankruptcy". Reuters. https://www.reuters.com/article/legal/in-brief-bioserenity-to-buy-novasom-out-of-bankruptcy-idUSL2N26E1UQ/. 
  21. "Les usines de l'Hexagone en ordre de bataille pour les protections sanitaires" (in fr). 2020-07-28. https://www.lefigaro.fr/societes/les-usines-de-l-hexagone-en-ordre-de-bataille-pour-les-protections-sanitaires-20200728. 
  22. Ledoux, Aurélie (2009). "Vidéos en ligne : la preuve par l'image ?". Esprit Mars/avril (3): 95–106. doi:10.3917/espri.0903.0095. ISSN 0014-0759. http://dx.doi.org/10.3917/espri.0903.0095. 
  23. "About us" (in en). https://group.bioserenity.com/en/nous-connaitre. 
  24. "ICECap" (in en-US). https://bioserenity.com/icecap/. 
  25. "Research" (in en-US). https://bioserenity.com/research/. 
  26. Rahmouni, Mohamed; Bussalb, Aurore; Elbaz, Maxime; Jubien, Guillaume; Gimenez, Ulysse (2024-03-01). "Algorithmes de détection de micro-éveils de haute performance avec un modèle de deep learning". Médecine du Sommeil. Le congrès du sommeil 21 (1): 8. doi:10.1016/j.msom.2023.12.014. ISSN 1769-4493. https://www.sciencedirect.com/science/article/pii/S1769449323003631. 
  27. Hanif, Umaer; Gimenez, Ulysse; Cairns, Alyssa; Lewin, Daniel; Ashraf, Nisar; Mignot, Emmanuel (July 2023). "Automatic Detection of Chronic Insomnia from Polysomnographic and Clinical Variables Using Machine Learning". 2023 45th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC). 2023. pp. 1–5. doi:10.1109/EMBC40787.2023.10340587. ISBN 979-8-3503-2447-1. https://pubmed.ncbi.nlm.nih.gov/38083711. 
  28. "Emmanuel Mougeotte is BIOSerenity's new CEO" (in en-GB). https://www.jolt-capital.com/news/emmanuel-mougeotte-is-bioserenitys-new-ceo. 
  29. Bettinardi, Ruggero G.; Rahmouni, Mohamed; Gimenez, Ulysse (2025-03-13), BioSerenity-E1: a self-supervised EEG model for medical applications, http://arxiv.org/abs/2503.10362, retrieved 2026-01-22 
  30. "Stratus Partners with BioSerenity to Become U.S. Distributor of IceCap® Product Line" (in en). https://stratusneuro.com/resources/stratus-to-become-us-distributor-of-icecap. 
  31. "Emmanuel Mougeotte is BIOSerenity's new CEO" (in en-GB). https://www.jolt-capital.com/news/emmanuel-mougeotte-is-bioserenitys-new-ceo. 
  32. "Former CEO concludes his tenure after 11 years" (in en-GB). https://www.jolt-capital.com/news/former-ceo-concludes-his-tenure-after-11-years. 
  33. "BioSerenity" (in en). http://2016.disrupt100.com/company/bioserenity/. 
  34. "BioSerenity" (in fr-FR). November 25, 2014. https://next40.org/bioserenity/. 
  35. "These 6 startups were selected to join Microsoft and AstraZeneca's AI Factory for Health" (in en). March 12, 2020. https://www.bioportfolio.com/news/article/4233478/These-6-startups-were-selected-to-join-Microsoft-and-AstraZenecas-AI-Factory.html. 
  36. "Companies" (in en). https://startx.com/companies.